Article Text

Download PDFPDF

O17.3 Declining rates of cervical intraepithelial NEOPLASIA after introduction of the HPV vaccine in british columbia, canada
Free
  1. Robine Donken1,
  2. Dirk Van Niekerk2,
  3. Jeremy Hamm2,
  4. Laurie Smith2,
  5. Manish Sadarangani3,
  6. Monika Naus4,
  7. Deborah Money5,
  8. Simon Dobson6,
  9. Dianne Miller4,
  10. Mel Krajden7,
  11. Marette Lee2,
  12. Sheona Mitchell-Foster8,
  13. John Spinelli2,
  14. Andrew Coldman9,
  15. Gina Ogilvie5
  1. 1BC Children’s Research Institute, Vaccine Evaluation Center, Vancouver, Canada
  2. 2BC Cancer, Vancouver, Canada
  3. 3BC Children’s Hospital Research Institute, Vaccine Evaluation Center, Vancouver, Canada
  4. 4University of British Columbia, Faculty of Medicine, Vancouver, Canada
  5. 5University of British Columbia, Vancouver, Canada
  6. 6Sidra Medicine, Doha, Qatar
  7. 7BC CDC, Vancouver, Canada
  8. 8University of Northern British Columbia, Northern Medical Program, Prince George, Canada
  9. 9BC Cancer Research Centre, Vancouver, Canada

Abstract

Background In 2008 British Columbia (BC), Canada, implemented a voluntary school-based HPV vaccination program for girls, born 1994 or later, with an average uptake of 63%. Given the long time-lead between infection and malignant disease, effects on cancer incidence will take decades to assess. To evaluate the early impact of the HPV vaccine in BC, ecological trends in cervical intraepithelial neoplasia (CIN) rates were assessed in young women before and after the implementation of the HPV vaccination program.

Methods From the population-based cervical cancer screening program database in BC, information on all Pap smears and histopathological abnormalities, in calendar years 2004–2017 in women under age 28 were obtained. Rates of cervical intraepithelial neoplasia (CIN) were calculated as the number of cases divided by the number of cytology specimens for that period. Incidence rate ratios (IRR) comparing pre- and post-vaccination years, adjusted for age and screening year, were calculated by piece-wise Poisson regression analysis. We performed a sensitivity analysis including only women eligible for routine screening.

Results The total number of screens in the unvaccinated cohort was 1,417,512 and in the vaccinated cohort 73,343. After the introduction of the HPV vaccination program in BC, a decrease in the incidence of CIN was observed in vaccine-eligible birth cohorts. The adjusted IRR for CIN1, 2 and 3 were respectively 0.60 (95%CI 0.53–0.67), 0.49 (95%CI 0.41–0.57) and 0.39 (95%CI 0.32–0.47). Sensitivity analysis confirmed these findings, also indicating a significant decline in CIN rates in birth cohorts eligible for the HPV vaccination program.

Conclusion This study illustrates the population impact of the provincial school-based HPV vaccination program, by an observed decline in rates of CIN since introduction of the program. Further evaluation of the population-based impact includes a linkage between vaccination and screening registry.

Disclosure No significant relationships.

  • HPV

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.